Advanced characterization of DNA molecules in rAAV vector preparations by single-stranded virus next-generation sequencing E Lecomte, B Tournaire, B Cogné, JB Dupont, P Lindenbaum, ... Molecular Therapy-Nucleic Acids 4, 2015 | 77 | 2015 |
Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset V Mournetas, E Massouridès, JB Dupont, E Kornobis, H Polvèche, ... Journal of cachexia, sarcopenia and muscle 12 (1), 209-232, 2021 | 34 | 2021 |
AAV-mediated gene transfer restores a normal muscle transcriptome in a canine model of X-linked myotubular myopathy JB Dupont, J Guo, E Renaud-Gabardos, K Poulard, V Latournerie, ... Molecular Therapy 28 (2), 382-393, 2020 | 25 | 2020 |
Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA JB Dupont, B Tournaire, C Georger, B Marolleau, L Jeanson-Leh, ... Molecular Therapy Methods & Clinical Development 2, 2015 | 23 | 2015 |
NGS library preparation may generate artifactual integration sites of AAV vectors B Cogné, R Snyder, P Lindenbaum, JB Dupont, R Redon, P Moullier, ... Nature Medicine 20 (6), 577-578, 2014 | 19 | 2014 |
CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis A Mérien, J Tahraoui-Bories, M Cailleret, JB Dupont, C Leteur, J Polentes, ... Human molecular genetics 31 (1), 41-56, 2022 | 17 | 2022 |
Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice SE Hamm, DD Fathalikhani, KE Bukovec, AK Addington, H Zhang, ... Molecular Therapy-Methods & Clinical Development 21, 144-160, 2021 | 16 | 2021 |
High-throughput, real-time monitoring of engineered skeletal muscle function using magnetic sensing AST Smith, SM Luttrell, JB Dupont, K Gray, D Lih, JW Fleming, ... Journal of tissue engineering 13, 20417314221122127, 2022 | 15 | 2022 |
Restriction factors against recombinant adeno-associated virus vectormediated gene transfer in dystrophin-deficient muscles JB Dupont Current Gene Therapy 16 (3), 168-183, 2016 | 3 | 2016 |
Rétrovirus humain XMRV: la fin d'une histoire séduisante S Assil, PA Bolze, M Boukhali, C Cariou, L Chauveau, N Chuvin, ... Virologie 15 (4), 222-34, 2011 | 3 | 2011 |
Myogenesis modelled by human pluripotent stem cells uncovers duchenne muscular dystrophy phenotypes prior to skeletal muscle commitment V Mournetas, E Massouridès, JB Dupont, E Kornobis, H Polvèche, ... BioRxiv, 720920, 2019 | 2 | 2019 |
Gene Therapy for X-Linked Myotubular Myopathy JB Dupont, MW Lawlor, MK Childers Muscle Gene Therapy, 565-577, 2019 | 1 | 2019 |
Transcriptomic Analysis Reveals the Inability of Recombinant AAV8 to Activate Human Monocyte-Derived Dendritic Cells S Masri, L Carré, N Jaulin, C Vandamme, C Couzinié, A Guy-Duché, ... International Journal of Molecular Sciences 24 (13), 10447, 2023 | | 2023 |
Dystrophin deficiency impairs cell junction formation during embryonic myogenesis E Mozin, E Massouridès, V Mournetas, C Lièvre, A Bourdon, DL Jackson, ... bioRxiv, 2023.12. 05.569919, 2023 | | 2023 |
Intramuscular delivery of rAAV in non-human primates results in a chronic local inflammation in situ without the loss of transgene expression M Journou, M Guilbaud, M Devaux, N Jaulin, JB Dupont, G Gernoux, ... HUMAN GENE THERAPY 32 (19-20), A27-A27, 2021 | | 2021 |
Genetic diseases in the omics era JB Dupont Molecular Therapy 29 (8), 2389-2390, 2021 | | 2021 |
AAV Intramuscular Gene Transfer in the Non-Human Primate Model Leads to an In Situ Immune Transcriptomic Signature M Journou, M Guilbaud, M Devaux, N Jaulin, JB Dupont, V Pichard, ... MOLECULAR THERAPY 29 (4), 353-353, 2021 | | 2021 |
LATE BREAKING NEWS E-POSTER PRESENTATION: LBP 4 Novel Epigenetic Small Molecule Approaches and Single-Cell Epigenetic Analysis for DMD L Maves, JB Dupont, GH Farr, S Luttrell, M Morris, A Gomez, T Pham, ... Neuromuscular Disorders 30, S168, 2020 | | 2020 |
Improvement of pluripotent stem cell-derived skeletal muscle myotube maturation through the combination of physical and chemical factors JB Dupont, E Massourides, V Mournetas, SM Luttrell, DL Mack, C Pinset HUMAN GENE THERAPY 30 (11), A131-A132, 2019 | | 2019 |
Single cell developmental trajectories reveal early phenotypes in Duchenne muscular dystrophy prior to skeletal muscle commitment JB Dupont, SM Luttrell, D Jackson, JS Packer, L Maves, C Trapnell, ... HUMAN GENE THERAPY 30 (11), A123-A123, 2019 | | 2019 |